Gene · 2867
Papers2,791
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,791
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microbiome and Asthma: Microbial Dysbiosis and the Origins, Phenotypes, Persistence, and Severity of Asthma. | Nutrients | 2023 | 36771193 | PubTator, text mining | PubMed |
| Health Benefits of Consuming Foods with Bacterial Probiotics, Postbiotics, and Their Metabolites: A Review. | Molecules | 2023 | 36770898 | PubTator, text mining | PubMed |
| Identification of Key Biomarkers Associated with Immunogenic Cell Death and Their Regulatory Mechanisms in Severe Acute Pancreatitis Based on WGCNA and Machine Learning. | Int J Mol Sci | 2023 | 36769358 | PubTator, text mining | PubMed |
| Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat. | Int J Mol Sci | 2023 | 36769034 | PubTator, text mining | PubMed |
| Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease. | Int J Mol Sci | 2023 | 36768785 | PubTator, text mining | PubMed |
| The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease. | Int J Mol Sci | 2023 | 36768722 | PubTator, text mining | PubMed |
| Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. | Cancers (Basel) | 2023 | 36765824 | PubTator, text mining | PubMed |
| The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications. | Front Pharmacol | 2023 | 36762113 | PubTator, text mining | PubMed |
| Communication of gut microbiota and brain via immune and neuroendocrine signaling. | Front Microbiol | 2023 | 36760508 | PubTator, text mining | PubMed |
| Microbiota-derived acetate enhances host antiviral response via NLRP3. | Nat Commun | 2023 | 36746963 | PubTator, text mining | PubMed |
| Butyrate limits the replication of porcine epidemic diarrhea virus in intestine epithelial cells by enhancing GPR43-mediated IFN-III production. | Front Microbiol | 2023 | 36744090 | PubTator, text mining | PubMed |
| Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease. | Front Immunol | 2023 | 36742307 | PubTator, text mining | PubMed |
| Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease. | World J Gastroenterol | 2023 | 36742172 | PubTator, text mining | PubMed |
| Is there a role for microbiome-based approach in common variable immunodeficiency? | Clin Exp Med | 2023 | 36737487 | PubTator, text mining | PubMed |
| Disturbance of lipid metabolism in germ-free mice transplanted with gut microbiota of DSS-induced colitis mice. | PLoS One | 2023 | 36735734 | PubTator, text mining | PubMed |
| The direct correlation between microbiota and SARS-CoV-2 infectious disease. | Inflammopharmacology | 2023 | 36725821 | PubTator, text mining | PubMed |
| Effects of free fatty acid receptor-2 (FFAR2)-mediated signaling on the regulation of cellular functions in osteosarcoma cells. | Biochem Biophys Res Commun | 2023 | 36706706 | PubTator, text mining | PubMed |
| Gut microbial metabolites lower blood pressure in patients with hypertension. | Nat Cardiovasc Res | 2023 | 36688212 | PubTator, text mining | PubMed |
| Role of natural products and intestinal flora on type 2 diabetes mellitus treatment. | World J Clin Cases | 2023 | 36687192 | PubTator, text mining | PubMed |
The Pivotal Role of Aryl Hydrocarbon Receptor-Regulated Tight Junction Proteins and Innate Immunity on the Synergistic Effects of Postbiotic Butyrate and Active Vitamin D3 to Defense against Microbial Invasion in Salmonella Colitis. | Nutrients | 2023 | 36678175 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2867/papers?page=35